National Coverage Analysis (NCA)

Intravenous Immune Globulin for Autoimmune Mucocutaneous Blistering Diseases

CAG-00109N

Expand All | Collapse All

Contacts

Kim Long
Kimberly.long@cms.hhs.gov
410-786-5702
Lead Analysts
Lead Medical Officers

History of Considerations

History Title ID
Original Consideration Intravenous Immune Globulin for Autoimmune Mucocutaneous Blistering Diseases CAG-00109N You are here